Donald A. McGovern Jr. - 18 May 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ Donald A. McGovern, Jr.
Issuer symbol
ATNF
Transactions as of
18 May 2023
Net transactions value
+$16,300
Form type
4
Filing time
22 May 2023, 08:00:31 UTC
Previous filing
02 Dec 2022
Next filing
01 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Purchase $10,500 +10,000 +196% $1.05 15,099 18 May 2023 Direct F1
transaction ATNF Common Stock Purchase $5,800 +5,000 +33% $1.16 20,099 19 May 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $1.0298 to $1.0497, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $1.155 to $1.1599, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.